Trials / Terminated
TerminatedNCT04969406
A Prospective Trial of the Intelon BOSS(TM) System
A Prospective Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(TM) System
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Intelon Optics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A prospective, open-label, single-site clinical trial designed to evaluate the repeatability and reproducibility of biomechanical imaging by the BOSS device. Subjects will undergo unilateral biomechanical mapping of the cornea and lens by three BOSS devices operated by three (3) different operators.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Brillouin Spectroscopy via BOSS System | Biomechanical Imaging of the Cornea and Lens |
Timeline
- Start date
- 2021-07-24
- Primary completion
- 2021-12-10
- Completion
- 2021-12-10
- First posted
- 2021-07-20
- Last updated
- 2022-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04969406. Inclusion in this directory is not an endorsement.